The device offers human-like dexterity, offering hope for amputees and vast potential as a remote control limb for hazardous tasks.
The advanced healthcare platform offers tools for chronic disease management and improved patient experiences.
The Cupertino company is reportedly exploring the benefits for pre-diabetic users, though public release plans remain uncertain.
The Finnish tech company's fourth-gen Ring offers a sleeker design, improved sensors, and smarter health insights, along with a revamped app.
The company has also launched THRIVE, a unique personal transformation program designed to rejuvenate the mind and body.
The AI model, called AlphaProteo, can design targeted protein binders, promising breakthroughs in cancer treatments and diseases like diabetes.
The tiny DNA-based robots target and destroy diseased cells while sparing healthy tissue.
The Abu Dhabi-based company hopes to treat idiopathic pulmonary fibrosis, and has 30 more drugs in the pipeline.
The health-tech company will use the funding to continue its global disruption of the supplements market.
According to CEO Noor Siddiqui, the company isn’t on a mission to make designer babies, but aims to beat genetic odds and relieve suffering.
